Quantitative Method for the Determination of Potentially Mutagenic Impurities of Ondansetron Using UPC2 Coupled with a Xevo TQ-S micro

Applications | 2017 | WatersInstrumentation
LC/MS, LC/MS/MS, LC/QQQ, SFC
Industries
Pharma & Biopharma
Manufacturer
Waters
Downloadable PDF for viewing
 

Similar PDF

Exploiting the Orthogonality of the ACQUITY UPC2 System  to Develop an Impurities Method for Ondansetron
The Direct Quantification of a Mutagenic Impurity, Methyl Amino Crotonate, Using ACQUITY UPC2 and QDa Detector
Analysis of Genotoxic Impurities of Imatinib Mesylate by LC-MS  from Early Development to Routine Monitoring
Trace Level Quantification of Potential Mutagenic Impurities in Pharmaceuticals